木瓜直播

Critical Care >

CHF

News, opinions and meeting coverage in critical care.

AHA: Real World TAVR Is All About Patient Selection

Intermediate risk is a moving target

AHA: Long-Term Benefit in HF Patients Elusive for Novel Vasodilator

Investigational drug ularitide had no effect on mortality or clinical outcomes

TCT: TAVR Holds Up Pretty Well Over Time

Also, 2-year data confirm lasting improvements in QoL

TCT: Embolic Protection Flops for TAVR

New brain lesions or clinical strokes unaffected in SENTINEL trial

CardioBrief: Impella No Better Than IABP in Cardiogenic Shock

Underpowered IMPRESS trial shows no mortality benefit

HFSA: Clinical Benefits Tied To Lung Monitoring Persist

HF rehospitalization, deaths remain reduced up to 4.5 years

Cardiac Myosin Activator Shows Promise for LV Function

'More hands pulling on the rope'

HFSA: Treat to NT-proBNP Target Flops in Trial

Outcomes no better with treatment aimed at 30% reduction

HFSA: Did LAP Monitoring Cut HF Rehospitalizations?

LAPTOP-HF investigators tried to make sense of terminated study

ESC: Beta-Blocker Cuts Early Heart Damage from Cancer Tx?

No clinical difference in small trial, but preclinical measures suggestive

ESC: No Mortality Benefit With ICD in Nonischemic HF

Eleven fewer deaths over 5 years

Stores' Security Systems Can Mess With Cardiac Devices

ICD, pacemaker hiccups seen near anti-shoplifting monitors in lab study

Compression Stockings; Stroke Prevention; Stents and Meds

Cardiovascular Daily wraps up the top cardiology news of the week

Survival Rates Good With VAD for Complicated Acute MI

Despite being sicker to start, outcomes on par with other VAD patients

Podcast: 10th Anniversary for HealthNewsReview.org

Gary Schwitzer reflects on high points, low points, lessons learned

ACC: After a Decade, CABG Pulls Ahead of Meds for HF

Life-saving benefit of CABG now clear in long-term trial follow-up

Entresto: Why Is There Silence? We're Not Selling iPhones

The drug hailed as a true PARADIGM shift, is slow out of the gate

ACC: TAVR Once Again Non-Inferior to Surgery

No excess stroke or mortality at 2 years in lowest risk trial population yet studied

CardioBrief: Top HF Expert Decries 'Unbelievable Folly' of Clinical Trials and Guidelines

Milton Packer, MD, calls the system to test and evaluate heart failure drugs dysfunctional

CardioBrief: LVADs Prolong Life But Sow Confusion at Its End

Uncertainty dogs heart pump patients and their caregivers

First MRI-Safe CRT-D Devices Approved

Cardiac resynchronization patients may now undergo scans

CardioBrief: Entresto Maker in Deep Water Over Terrifying TV Ad

"Alarmist," "horrifying" and "irresponsible," experts say

CardioBrief: Entresto Off to Slow Start

'Blockbuster' heart failure drug falls short of already low sales expectations

AHA: Long-Acting Nitrate Flops in HFpEF

Study does not support the use of nitrates in subgroup of heart failure patients

Is SAMHSA to Blame for a Broken Mental Health System?

Two members of Congress differ on how to fix a failing system

Safety Warning: Watch LVAD Battery Expiration

Ventricular support backup battery issue linked to two deaths

CardioBrief: Dollars for Heart Docs

Analysis of CMS database shows some docs pocketed millions from drug and device makers.

10 Questions: Mary Norine Walsh, MD

"The waste will continue until the method of reimbursement changes."

Doctor's Memoir Exposes Dark Side of Medicine

Sandeep Jauhar puts his life on stark display to illustrate harmful financial intrusions into medicine in his newest book.

CardioBuzz: Toward the $500 an Hour Physician

In this guest blog, Mark Jay Zucker, MD, JD, an attorney and transplant cardiologist at Rutgers University New Jersey 木瓜直播 School in Newark, explains why he thinks it's time to talk money.

How To Get Medicare To Cover A Spa Trip

Good news for doctors who think their patients need a trip to the spa: Medicare will reimburse, with only two catches.

How to Replace IV Nitroglycerin in the Shortage

What are the alternatives for IV nitroglycerin in the emergency setting as the shortage saps reserves? Several experts share their thoughts.

CT Appears Safe in Patients With Pacemakers, ICDs

Patients with cardiac rhythm management devices showed no clinically significant major or minor events related to computed tomography imaging over a 10-year period at two large-volume care centers, researchers reported.

ER Briefs: DIY Laptop to AED Kit -- Good Idea?

Inventors aim to resurrect laptops and tablets as AEDs. We asked Clifton Callaway, MD, PhD, an emergency medicine doctor who heads up EM research at the University of Pittsburgh, to weigh in.

FDA Flags Risk of Nuclear Stress Test Drugs

SILVER SPRING, Md. -- Two agents used in cardiac nuclear stress tests may carry a greater risk of heart attack and death than previously believed, the FDA said Wednesday.

Randy Travis Gets an LVAD, Future Uncertain

Grammy award-winning country music star Randy Travis has received the Impella pump, a temporary percutaneous left ventricular assist device, to help him as he battles viral cardiomyopathy, according to his publicist.

Xarelto Gets a No for Stent Thrombosis

SILVER SPRING, Md. -- The FDA has rejected an application for a new indication allowing rivaroxaban (Xarelto) to be used to reduce the risk of stent thrombosis in patients with acute coronary syndrome.

Hypothyroidism Hikes Death Risk in Blacks

African Americans with hypothyroidism face an increased risk of death, and in patients with congestive heart failure, even mild underactive thyroid disease raises mortality risk, a retrospective cohort study found.

Is Protein the Key to Fountain of Youth?

The cardiac clocks of aging mice were turned back to a more youthful time when they received a protein taken from the blood of younger mice, researchers found.

ACC: Is Chelation Plus Vitamins a Winning Combo?

SAN FRANCISCO -- Vitamins alone won't improve outcomes for patients who've had a heart attack, but they do appear to have additive benefits when given in conjunction with controversial chelation therapy, researchers reported here.

鈥�

12